Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention developmentShivani Garg, Betty Chewning, David Gazeley, Shelby Gomez, Noah Kaitz, Amanda C Weber, Ann Rosenthal, Christie Bartels
1 August 2022
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritisTheerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Wonngarm Kittanamongkolchai
28 July 2022
Social Factors, Epigenomics and Lupus in African American Women (SELA) Study: protocol for an observational mechanistic study examining the interplay of multiple individual and social factors on lupus outcomes in a health disparity populationEmily L Vara, Carl D Langefeld, Bethany J Wolf, Timothy D Howard, Gregory A Hawkins, Queen Quet, Lee H Moultrie, L Quinnette King, Ivan D Molano, Stephanie L Bray, Lori Ann Ueberroth, S Sam Lim, Edith M Williams, Diane L Kamen, Paula S Ramos
29 June 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre studyChiara Tani, Dina Zucchi, Isabell Haase, Maria Gerosa, Maddalena Larosa, Lorenzo Cavagna, Alessandra Bortoluzzi, Francesca Crisafulli, Johanna Mucke, Francesca A L Strigini, Laura Baglietto, Marco Fornili, Francesca Monacci, Elena Elefante, Roberta ErraSee the full list of authors
14 June 2022
Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysisTakehiro Nakai, Sho Fukui, Yukihiko Ikeda, Masei Suda, Hiromichi Tamaki, Masato Okada
2 June 2022
Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018Shannon Grabich, Eileen Farrelly, Robert Ortmann, Michael Pollack, Sandra Sze-jung Wu
24 May 2022
Predictors of refractory risk in systemic lupus erythematosus-related thrombocytopenia: a dual-centre retrospective studyKaisheng Su, Hao Cheng, Zhifang Jia, Yi Yuan, Huidan Yang, Qi Gao, Zhenyu Jiang, Hongyan Wen, Jing Jiang
20 May 2022
Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activityFangfang Sun, Liling Zhao, Haiting Wang, Danting Zhang, Jie Chen, Xiaodong Wang, Ting Li, Shuang Ye
20 May 2022
Coping with systemic lupus erythematosus in patients’ wordsAlain Cornet, Davide Mazzoni, Angela Edwards, Dario Monzani, Gabriella Pravettoni, Jeanette Andersen, Marta Mosca
13 May 2022
Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation studyAurelien Schlencker, Laurent Messer, Marc Ardizzone, Gilles Blaison, Olivier Hinschberger, Etienne Dahan, Christelle Sordet, Julia Walther, Anne Dory, Maria Gonzalez, Stéphanie Kleinlogel, Aurélia Bramont-Nachman, Lionel Barrand, Isabelle Payen-Revol, Jean SibiliaSee the full list of authors
13 May 2022